Tag: medical device
-
BARDA Funding Vaccine Patch Clinical Trial
The U.S. government’s medical preparedness agency is funding a clinical trial of a patch that dispenses vaccines with a much lower dose than syringes.
-
Wireless Sensor Detects Multiple Covid-19 Indicators
Biomedical engineers designed a lab-on-a-chip sensor that quickly detects SARS-CoV-2 viruses in saliva or blood, as well as antibodies and indicators of disease severity.
-
Group Advancing Electronic Spinal Cord Injury Therapies
A consortium of academic and industry labs is integrating electronic sensors and neural stimulation therapies into an early treatment protocol for spinal cord injuries.
-
Study Testing Wearables Data for Covid-19 Clues
A biomedical engineering lab and analytics company are testing the feasibility of algorithms to find early signs of Covid-19 symptoms from smart watch users.
-
App Tracks Public Mask Wearing for Covid-19 Evidence
A mobile app is now available for individuals to count — NOT report — people wearing face masks, as an indicator of Covid-19 community infection spread.
-
Dexcom, UVirginia Partner on Diabetes Technology
Dexcom Inc., a maker of glucose monitoring systems, and University of Virginia are collaborating on extending the company’s current technologies to cover more types of diabetes
-
Home Eye Pressure Gauge in the Works
An easy-to-use device for measuring intraocular pressure responsible for glaucoma is in development by University of Pittsburgh biomedical engineers.
-
Univ Lab, Company Developing Phone-Based Virus Sensor
A biotechnology company is sponsoring university research on light waves reacting in characteristic patterns for detecting SARS-CoV-2 viruses by a smartphone camera.
-
Quick Crispr-Based Test Detects Malaria in Blood
A blood test designed for low-resource field settings is shown to quickly detect and distinguish between different malaria parasites needed to accurately diagnose the disease.
-
Cancer Screening Analytics Company Acquired in $8B Deal
A company creating a blood test to screen for multiple types of cancer is being acquired by genomics analytics company Illumina for $8 billion in cash and stock.